L Vigorè

531 total citations
22 papers, 365 citations indexed

About

L Vigorè is a scholar working on Immunology, Oncology and Endocrine and Autonomic Systems. According to data from OpenAlex, L Vigorè has authored 22 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in L Vigorè's work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). L Vigorè is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). L Vigorè collaborates with scholars based in Italy. L Vigorè's co-authors include Paolo Lissoni, Franco Rovelli, Luca Fumagalli, F Brivio, Giusy Messina, Luca Fumagalli, Fernando Brivio, Mario Mandalà, R Bucovec and Sofia Meregalli and has published in prestigious journals such as Cancer Research, European Journal of Cancer and Methods in molecular biology.

In The Last Decade

L Vigorè

20 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Vigorè Italy 10 162 149 78 74 34 22 365
F Brivio Italy 11 94 0.6× 101 0.7× 136 1.7× 55 0.7× 30 0.9× 21 359
Pascal Bleuzen France 7 82 0.5× 254 1.7× 219 2.8× 73 1.0× 71 2.1× 10 636
Giusy Messina Italy 9 52 0.3× 80 0.5× 77 1.0× 105 1.4× 121 3.6× 36 368
Norihiko Murakami Japan 8 103 0.6× 35 0.2× 38 0.5× 43 0.6× 29 0.9× 17 374
Kashif Asghar Pakistan 11 123 0.8× 80 0.5× 15 0.2× 128 1.7× 38 1.1× 29 479
Jessica M. Sido United States 10 294 1.8× 140 0.9× 14 0.2× 103 1.4× 7 0.2× 13 503
Ying Xia China 11 55 0.3× 117 0.8× 20 0.3× 46 0.6× 85 2.5× 27 303
Hee‐Cheol Kim South Korea 6 63 0.4× 64 0.4× 18 0.2× 82 1.1× 61 1.8× 18 335
Janine Golchert Germany 9 136 0.8× 168 1.1× 7 0.1× 207 2.8× 34 1.0× 16 629
Rie Kawaguchi Japan 8 186 1.1× 100 0.7× 8 0.1× 95 1.3× 38 1.1× 21 501

Countries citing papers authored by L Vigorè

Since Specialization
Citations

This map shows the geographic impact of L Vigorè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Vigorè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Vigorè more than expected).

Fields of papers citing papers by L Vigorè

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Vigorè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Vigorè. The network helps show where L Vigorè may publish in the future.

Co-authorship network of co-authors of L Vigorè

This figure shows the co-authorship network connecting the top 25 collaborators of L Vigorè. A scholar is included among the top collaborators of L Vigorè based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Vigorè. L Vigorè is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lissoni, Paolo, et al.. (2018). How to Monitor the Neuroimmune Biological Response in Patients Affected by Immune Alteration-Related Systemic Diseases. Methods in molecular biology. 171–191. 6 indexed citations
3.
Vigorè, L, Giusy Messina, Fernando Brivio, et al.. (2011). Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.. PubMed. 24(5). 787–9. 24 indexed citations
4.
Lissoni, Paolo, Fernando Brivio, Luca Fumagalli, et al.. (2008). Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.. PubMed. 28(2B). 1377–81. 53 indexed citations
5.
Lissoni, Paolo, Giovanni Messina, F Brivio, et al.. (2008). A spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patients.. PubMed. 22(5). 577–81. 24 indexed citations
6.
Brivio, F, Paolo Lissoni, Luca Fumagalli, et al.. (2008). Correlation between soluble IL-2 receptor serum levels and regulatory T lymphocytes in patients with solid tumors. The International Journal of Biological Markers. 23(2). 121–122. 5 indexed citations
7.
Brivio, F, Luca Fumagalli, Giovanni Messina, et al.. (2008). T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients.. PubMed. 22(5). 647–50. 15 indexed citations
8.
Lissoni, Paolo, Fabio Malugani, R Bucovec, et al.. (2002). Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.. PubMed. 15(2). 140–4. 88 indexed citations
9.
Brivio, F, Paolo Lissoni, L Vigorè, et al.. (2001). Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients.. PubMed. 14(3). 200–3. 6 indexed citations
10.
Brivio, Fernando, R Rescaldani, L Vigorè, et al.. (2001). Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression.. PubMed. 47(35). 1337–9. 13 indexed citations
11.
Lissoni, P., L Vigorè, R Ferranti, et al.. (2000). Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease.. PubMed. 13(4). 216–9. 39 indexed citations
12.
Lissoni, Paolo, F Brivio, L Vigorè, et al.. (2000). Circulating Immature and Mature Dendritic Cells in Relation to Lymphocyte Subsets in Patients with Gastrointestinal Tract Cancer. The International Journal of Biological Markers. 15(1). 22–25. 15 indexed citations
13.
14.
Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1998). Immunobiological effects of interleukin-2, interleukin-12 or interleukin-2 plus interleukin-12 in metastatic cancer patients. 14(1). 41–44. 1 indexed citations
15.
Lissoni, Paolo, et al.. (1997). Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer.. PubMed. 9(2). 63–6. 11 indexed citations
16.
Lissoni, Paolo, L Vigorè, R Rescaldani, et al.. (1996). Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study.. PubMed. 9(4). 155–8. 9 indexed citations
17.
Lissoni, Paolo, Sandro Barni, E. Scardino, et al.. (1994). Lymphocytosis Decline is not Responsible for Tumor Progression in Cancer Patients Chronically Treated with Interleukin-2. Tumori Journal. 80(4). 283–285.
18.
Lissoni, Paolo, Sandro Barni, Franco Rovelli, et al.. (1993). In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer. European Journal of Cancer. 29(8). 1127–1132. 8 indexed citations
19.
20.
Vigorè, L, et al.. (1983). Severe Peritonitis during CAPD Due to Beta-hemolytic Streptococcus, Lancefield Group A. Peritoneal Dialysis International. 3(2). 109–109. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Brivio Breakdown of academic impact, for papers by Pascal Bleuzen Breakdown of academic impact, for papers by Giusy Messina Breakdown of academic impact, for papers by Norihiko Murakami Breakdown of academic impact, for papers by Kashif Asghar Breakdown of academic impact, for papers by Jessica M. Sido Breakdown of academic impact, for papers by Ying Xia Breakdown of academic impact, for papers by Hee‐Cheol Kim Breakdown of academic impact, for papers by Janine Golchert Breakdown of academic impact, for papers by Rie Kawaguchi
Rankless by CCL
2026